马斯克脑机公司将在英国启动临床研究，测试意念控制

Group 1 - Neuralink is launching a clinical study in the UK to test its brain-computer interface chips that help severely paralyzed patients control digital and physical tools using their thoughts [2] - The company is collaborating with University College London Hospitals NHS Trust and Newcastle Hospitals for this research [2] - Patients with paralysis due to spinal cord injuries or amyotrophic lateral sclerosis (ALS) are eligible to participate, with five severely paralyzed patients already using the device [2] Group 2 - Neuralink raised $650 million in its latest funding round and has raised approximately $1.3 billion from investors to date, with a valuation of about $9 billion [3] - The company plans to begin human trials of its brain-computer interface in 2024 after addressing safety concerns raised by the FDA, which had previously rejected its application in 2022 [2]